Skip to search.
 FTSE 100 Up 0.64%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
511.88 Up 5.25(1.04%) 14:55 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:506.63
Open:509.05
Bid:508.41 x 100
Ask:509.65 x 100
1y Target Est:503.74
Beta:0.67
Earnings Date:3 Aug - 7 Aug (Est.)
Day's Range:505.55 - 512.23
52wk Range:269.50 - 519.46
Volume:60,883
Avg Vol (3m):836,475
Market Cap:52.87b
P/E (ttm):164.22
EPS (ttm):3.12
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 1.04%52.87b
AMGNUp 0.79%121.86b
NVSUp 1.20%249.37b
RHHBYUp 1.20%N/A

Key Statistics

Forward P/E (1 yr):38.17
P/S (ttm):16.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :11.10
Quarterly EPS Est (Jun-15) :2.75
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback